JP2018138533A - Hair Cosmetics - Google Patents
Hair Cosmetics Download PDFInfo
- Publication number
- JP2018138533A JP2018138533A JP2017033749A JP2017033749A JP2018138533A JP 2018138533 A JP2018138533 A JP 2018138533A JP 2017033749 A JP2017033749 A JP 2017033749A JP 2017033749 A JP2017033749 A JP 2017033749A JP 2018138533 A JP2018138533 A JP 2018138533A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- hair
- inulin
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003676 hair preparation Substances 0.000 title abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 131
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims abstract description 76
- 210000004209 hair Anatomy 0.000 claims abstract description 50
- 229920001202 Inulin Polymers 0.000 claims abstract description 41
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 41
- 229940029339 inulin Drugs 0.000 claims abstract description 41
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims abstract description 37
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000004883 caffeic acid Nutrition 0.000 claims abstract description 36
- 229940074360 caffeic acid Drugs 0.000 claims abstract description 36
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims abstract description 35
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims abstract description 33
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims abstract description 33
- 239000004480 active ingredient Substances 0.000 claims abstract description 23
- 239000002537 cosmetic Substances 0.000 claims abstract description 16
- 108010044493 collagen type XVII Proteins 0.000 claims description 18
- 230000037319 collagen production Effects 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 15
- 108010035532 Collagen Proteins 0.000 abstract description 13
- 102000008186 Collagen Human genes 0.000 abstract description 11
- 229920001436 collagen Polymers 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000003450 growing effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 36
- -1 ph adjusters Substances 0.000 description 32
- 239000000203 mixture Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 230000003779 hair growth Effects 0.000 description 26
- 238000009472 formulation Methods 0.000 description 24
- 239000012488 sample solution Substances 0.000 description 21
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 19
- 241000196324 Embryophyta Species 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 17
- 238000000605 extraction Methods 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 240000007594 Oryza sativa Species 0.000 description 13
- 235000007164 Oryza sativa Nutrition 0.000 description 13
- 235000009566 rice Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 241000208843 Arctium Species 0.000 description 12
- 235000003130 Arctium lappa Nutrition 0.000 description 12
- 235000008078 Arctium minus Nutrition 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 210000004761 scalp Anatomy 0.000 description 11
- 229940058015 1,3-butylene glycol Drugs 0.000 description 10
- 201000004384 Alopecia Diseases 0.000 description 10
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 239000000419 plant extract Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 8
- 210000003780 hair follicle Anatomy 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 7
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 7
- 229940074393 chlorogenic acid Drugs 0.000 description 7
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 7
- 235000001368 chlorogenic acid Nutrition 0.000 description 7
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 230000031774 hair cycle Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 150000004804 polysaccharides Chemical class 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 6
- 108010085238 Actins Proteins 0.000 description 5
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 5
- 235000017491 Bambusa tulda Nutrition 0.000 description 5
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 244000082204 Phyllostachys viridis Species 0.000 description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 229960005305 adenosine Drugs 0.000 description 5
- 239000011425 bamboo Substances 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000000284 resting effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 241001071795 Gentiana Species 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 244000070406 Malus silvestris Species 0.000 description 4
- 235000002597 Solanum melongena Nutrition 0.000 description 4
- 244000061458 Solanum melongena Species 0.000 description 4
- 231100000360 alopecia Toxicity 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 240000007154 Coffea arabica Species 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229940063333 burdock root extract Drugs 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229960003632 minoxidil Drugs 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 235000013322 soy milk Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- PMUWWDBIGFMHAW-SJORKVTESA-N (2r,3r)-3-hydroxy-3-methyl-2-(4-methylphenyl)-2h-chromen-4-one Chemical compound C1=CC(C)=CC=C1[C@@H]1[C@](O)(C)C(=O)C2=CC=CC=C2O1 PMUWWDBIGFMHAW-SJORKVTESA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- 239000012110 Alexa Fluor 594 Substances 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 244000019459 Cynara cardunculus Species 0.000 description 2
- 235000019106 Cynara scolymus Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000016520 artichoke thistle Nutrition 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002107 sheath cell Anatomy 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- HUXWBFFRUHXOBU-CPRQJHDUSA-N (E,5R,6S,7R,8R)-1-(3,4-dihydroxyphenyl)-5,6,7,8,9-pentahydroxynon-1-ene-3,4-dione Chemical compound C(\C=C\C1=CC(O)=C(O)C=C1)(=O)C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HUXWBFFRUHXOBU-CPRQJHDUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LNJRMYPOKFOJBQ-UHFFFAOYSA-N 1-(4-tert-butyl-4-methoxycyclohexa-1,5-dien-1-yl)ethanone Chemical compound COC1(C(C)(C)C)CC=C(C(C)=O)C=C1 LNJRMYPOKFOJBQ-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- IRYMDURTWYFRBH-UHFFFAOYSA-N 2-(7h-purin-2-ylmethyl)aniline Chemical compound NC1=CC=CC=C1CC1=NC=C(NC=N2)C2=N1 IRYMDURTWYFRBH-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- UFCLZKMFXSILNL-AALYGJCLSA-N 3,4-Dicaffeoylquinic acid Natural products O=C(O[C@@H]1[C@H](OC(=O)/C=C/c2cc(O)c(O)cc2)C[C@](O)(C(=O)O)C[C@@H]1O)/C=C/c1cc(O)c(O)cc1 UFCLZKMFXSILNL-AALYGJCLSA-N 0.000 description 1
- UFCLZKMFXSILNL-BKUKFAEQSA-N 3,4-di-O-caffeoylquinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O UFCLZKMFXSILNL-BKUKFAEQSA-N 0.000 description 1
- MCGBIXXDQFWVDW-UHFFFAOYSA-N 4,5-dihydro-1h-pyrazole Chemical compound C1CC=NN1 MCGBIXXDQFWVDW-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- GYFFKZTYYAFCTR-JUHZACGLSA-N 4-O-trans-caffeoylquinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-JUHZACGLSA-N 0.000 description 1
- DSHJQVWTBAAJDN-SMKXDYDZSA-N 4-caffeoylquinic acid Natural products CO[C@@]1(C[C@@H](O)[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@H](O)C1)C(=O)O DSHJQVWTBAAJDN-SMKXDYDZSA-N 0.000 description 1
- CWVRJTMFETXNAD-GMZLATJGSA-N 5-Caffeoyl quinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-GMZLATJGSA-N 0.000 description 1
- GYFFKZTYYAFCTR-UHFFFAOYSA-N 5-O-(6'-O-galloyl)-beta-D-glucopyranosylgentisic acid Natural products OC1CC(O)(C(O)=O)CC(O)C1OC(=O)C=CC1=CC=C(O)C(O)=C1 GYFFKZTYYAFCTR-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000307888 Acanthus ebracteatus Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000021317 Annona cherimola Species 0.000 description 1
- 241000156724 Antirhea Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- GYFFKZTYYAFCTR-ZNEHSRBWSA-N Cryptochlorogensaeure Natural products O[C@@H]1C[C@@](O)(C[C@@H](O)[C@@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O GYFFKZTYYAFCTR-ZNEHSRBWSA-N 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-fructofuranose group Chemical group OCC1(O)[C@@H](O)[C@H](O)[C@H](O1)CO RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 244000033273 Dahlia variabilis Species 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- UFCLZKMFXSILNL-PSEXTPKNSA-N Isochlorogenic acid b Chemical compound O([C@@H]1C[C@@](O)(C[C@H]([C@H]1OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)O)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-PSEXTPKNSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000012110 Pandanus odorus Nutrition 0.000 description 1
- 244000180021 Pandanus odorus Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 235000011402 Rosa x damascena Nutrition 0.000 description 1
- 240000004978 Rosa x damascena Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 235000001329 Ziziphus joazeiro Nutrition 0.000 description 1
- 244000158786 Ziziphus joazeiro Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- WQSDYZZEIBAPIN-UHFFFAOYSA-N caffeoylglucose Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C=CC1=CC=C(O)C(O)=C1 WQSDYZZEIBAPIN-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 235000012547 cherimoya Nutrition 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 229940105039 coconut extract Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GYFFKZTYYAFCTR-LMRQPLJMSA-N cryptochlorogenic acid Natural products O[C@H]1C[C@@](O)(C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O GYFFKZTYYAFCTR-LMRQPLJMSA-N 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000000642 hair follicle dermal papilla cell Anatomy 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical group CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- NZSVKAITUCOVRM-UHFFFAOYSA-J tetrasodium 1,2-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)CP([O-])([O-])=O NZSVKAITUCOVRM-UHFFFAOYSA-J 0.000 description 1
- SLYPOVJCSQHITR-UHFFFAOYSA-N tioxolone Chemical compound OC1=CC=C2SC(=O)OC2=C1 SLYPOVJCSQHITR-UHFFFAOYSA-N 0.000 description 1
- 229960003070 tioxolone Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristoyl-sn-glycerol Natural products CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、天然物由来の生体安全性にすぐれた新規の機能性素材を含み、特に、育毛及び養毛効果を有する毛髪化粧料に関するものである。 The present invention relates to a hair cosmetic composition containing a novel functional material excellent in biological safety derived from a natural product, and in particular, having hair growth and nourishing effects.
近年、加齢、ストレス又は紫外線等の様々な要因により、頭皮がダメージを受け、男性だけでなく女性も毛髪のトラブルを抱える人が増加しており、これに対応して様々な毛髪化粧料が提案されている。従来、毛髪のトラブルとして、男性型脱毛症(壮年性脱毛症)や女性型脱毛症(女性に生じた男性型脱毛症)の研究が行われ、これらの脱毛症に男性ホルモンが関与していることが明らかとなり、毛髪トラブルの改善剤として様々な抗男性ホルモン剤や女性ホルモン様作用剤等が提案されている。 In recent years, due to various factors such as aging, stress or ultraviolet rays, the scalp has been damaged, and not only men but also women have problems with hair. Corresponding to this, various hair cosmetics are available. Proposed. Conventionally, studies on male pattern alopecia (major alopecia) and female pattern alopecia (male pattern alopecia in women) have been conducted as hair problems, and male hormones are involved in these alopecia As a result, various anti-androgenic hormones and female hormone-like agents have been proposed as agents for improving hair troubles.
以上のような頭皮の老化、不健全化を防ぎ、かつ、若々しい状態に保持するため、さらには、上述した頭皮ダメージや抜け毛のメカニズムの研究に基づいて、様々な育毛・養毛剤、脱毛抑制剤(育毛剤等と称する)が提案されている。育毛・養毛の効果を発揮する有効成分として、例えば、ミノキシジルやアデノシンが知られており、これらの成分を配合した育毛剤等が提案されている。しかし、従来の育毛剤等に配合される有効成分は、頭皮の刺激等の副作用を引き起こすことがあり、十分に効果がありかつ安全性の高い機能性素材が求められている。 In order to prevent the aging and unhealth of the scalp as described above and keep it in a youthful state, various hair-growth / hair-restoring agents and hair loss inhibitors are also based on the research on scalp damage and hair loss mechanisms described above. An agent (referred to as a hair restorer or the like) has been proposed. For example, minoxidil and adenosine are known as active ingredients that exhibit hair-growth / hair-growth effects, and hair-growth agents containing these ingredients have been proposed. However, active ingredients blended in conventional hair restorers and the like may cause side effects such as irritation of the scalp, and there is a need for functional materials that are sufficiently effective and highly safe.
以上の従来技術の課題を鋭意検討した結果、本発明者らは、イヌリン、キナ酸又はカフェ酸(コーヒー酸)若しくはその誘導体、或いはイヌリン、キナ酸、コーヒー酸及びその誘導体のうちの少なくとも1以上を含む植物の抽出物が、XVII型コラーゲン合成促進作用を有すること、さらに、すぐれた育毛・養毛の効果を有し、それらが毛髪化粧料の有効成分として有用であることを新たに見出して本発明を完成させるに至った。 As a result of intensive studies on the above problems of the prior art, the present inventors have found at least one of inulin, quinic acid, caffeic acid (caffeic acid) or a derivative thereof, or inulin, quinic acid, caffeic acid and a derivative thereof. It has been found that plant extracts containing sucrose have an action of promoting XVII type collagen synthesis, and also have excellent hair growth and hair restoration effects, and are useful as active ingredients in hair cosmetics. The present invention has been completed.
従来、イヌリン又はコーヒー酸又はその誘導体を化粧料の有効成分とする技術は、例えば、特許文献1〜3により公知である。しかし、イヌリン、キナ酸、イヌリン及びコーヒー酸又はその誘導体、並びにイヌリン、キナ酸、コーヒー酸及びその誘導体の少なくとも1以上を含む植物の抽出物が育毛・養毛の効果を発揮する毛髪化粧料の有効成分として利用できることについては知られていなかった。 Conventionally, the technique which uses inulin, caffeic acid, or its derivative as an active ingredient of cosmetics is known by patent documents 1-3, for example. However, in hair cosmetics wherein plant extracts containing at least one of inulin, quinic acid, inulin and caffeic acid or derivatives thereof and at least one of inulin, quinic acid, caffeic acid and derivatives thereof exhibit hair-growth / hair-growth effects. It has not been known that it can be used as an active ingredient.
以上の従来技術の課題を鋭意検討した結果、本発明者らは、イヌリン、キナ酸又はコーヒー酸若しくはその誘導体、或いはイヌリン、キナ酸、コーヒー酸及びその誘導体のうちの少なくとも1以上を含む植物抽出物が、XVII型コラーゲン合成促進作用を有すること、さらに、すぐれた育毛・養毛の効果を有し、これが毛髪化粧料用の組成物として有用であることを新たに見出して本発明を完成させるに至った。 As a result of intensive studies on the above-described problems of the prior art, the present inventors have extracted plant extracts containing at least one of inulin, quinic acid, caffeic acid or derivatives thereof, or inulin, quinic acid, caffeic acid and derivatives thereof. The present invention completes the present invention by newly discovering that the product has an action of promoting the synthesis of collagen type XVII, and also has an excellent hair growth / hair restoration effect, which is useful as a composition for hair cosmetics. It came to.
本発明は、イヌリン又はそれを含む植物若しくはその抽出物を有効成分とする毛髪化粧料である。
本発明は、イヌリンと、キナ酸又はコーヒー酸若しくはその誘導体とを有効成分とする毛髪化粧料である。
本発明は、イヌリンと、キナ酸又はコーヒー酸若しくはその誘導体とを含む植物又はその抽出物を有効成分とする毛髪化粧料である。
本発明は、イヌリン、キナ酸又はコーヒー酸若しくはその誘導体、或いはイヌリン、キナ酸、コーヒー酸及びその誘導体のうちの少なくとも1つ以上を含む植物又はその抽出物を有効成分とするXVII型コラーゲン産生促進剤である。
The present invention is a hair cosmetic comprising inulin, a plant containing the same, or an extract thereof as an active ingredient.
The present invention is a hair cosmetic comprising inulin and quinic acid or caffeic acid or a derivative thereof as active ingredients.
The present invention is a hair cosmetic comprising, as an active ingredient, a plant containing inulin and quinic acid, caffeic acid or a derivative thereof, or an extract thereof.
The present invention promotes the production of type XVII collagen comprising, as an active ingredient, a plant containing at least one of inulin, quinic acid, caffeic acid or derivatives thereof, or inulin, quinic acid, caffeic acid and derivatives thereof, or an extract thereof. It is an agent.
本発明は、イヌリン、キナ酸又はコーヒー酸若しくはその誘導体、或いはイヌリン、キナ酸、コーヒー酸及びその誘導体のうちの少なくとも1つ以上を含む植物又はその抽出物を有効成分とする毛髪化粧料であって、XVII型コラーゲン合成促進作用を有し、さらに、すぐれた育毛・養毛の効果を有する。 The present invention is a hair cosmetic comprising as an active ingredient a plant containing at least one of inulin, quinic acid, caffeic acid or a derivative thereof, or inulin, quinic acid, caffeic acid and a derivative thereof, or an extract thereof. In addition, it has an action of promoting XVII type collagen synthesis, and also has an excellent hair growth and nourishing effect.
本発明において、イヌリンとは、D-フルクトフラノースがβ-2→1結合を繰り返し、末端に1モルのD-グルコースが結合した多糖類である。 In the present invention, inulin is a polysaccharide in which D-fructofuranose repeats β-2 → 1 bonds and 1 mol of D-glucose is bonded to the terminal.
本発明において、コーヒー酸とは3,4-ジヒドロキシケイヒ酸である。コーヒー酸の誘導体としては、例えば、クロロゲン酸(3-カフェオイルキナ酸)が挙げられる。クロロゲン酸とは、コーヒー酸のカルボキシル基がキナ酸3位のヒドロキシ基と脱水縮合した構造を持つ化合物である。その他のコーヒー酸誘導体としては、例えば、4-カフェオイルキナ酸や3,4-ジカフェオイルキナ酸、カフェオイルグルコース等が挙げられる。キナ酸とは、1,3,4,5-テトラヒドロキシシクロヘキサンカルボン酸であり、上述したクロロゲン酸等の構成成分として植物中に含まれることが知られている。 In the present invention, caffeic acid is 3,4-dihydroxycinnamic acid. Examples of caffeic acid derivatives include chlorogenic acid (3-caffeoylquinic acid). Chlorogenic acid is a compound having a structure in which the carboxyl group of caffeic acid is dehydrated and condensed with the hydroxy group at the 3-position of quinic acid. Examples of other caffeic acid derivatives include 4-caffeoylquinic acid, 3,4-dicaffeoylquinic acid, and caffeoyl glucose. Quinic acid is 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid and is known to be contained in plants as a constituent component such as chlorogenic acid.
本発明において、イヌリン、キナ酸、コーヒー酸及びその誘導体は、市販品であっても、植物等の天然物から抽出処理により得られた抽出物でもよい。また、その植物抽出物は分離、精製、濃縮等の処理を施して、イヌリン、キナ酸、コーヒー酸及び/又はその誘導体の濃度を高めたものでもよい。 In the present invention, inulin, quinic acid, caffeic acid and derivatives thereof may be commercially available products or extracts obtained by extraction from natural products such as plants. Further, the plant extract may be subjected to treatments such as separation, purification, and concentration to increase the concentration of inulin, quinic acid, caffeic acid and / or a derivative thereof.
本発明において使用可能な植物としては、以下のものが挙げられる。すなわち、イヌリンを含む植物としては、菊芋、葛芋、アザミ、チコリー、リュウゼツラン、ダーリア、アーティチョーク、タマネギ、ニンニク、ニラ等が挙げられる。また、キナ酸を含む植物としては、キナ樹皮、コーヒー、リンゴ、モモ等が挙げられる。また、コーヒー酸又はその誘導体を含む植物としては、ナス科・セリ科・キク科の植物や、リンゴ、かぼちゃ、さつまいも、コーヒー等が挙げられる。本発明においては、イヌリンとキナ酸、コーヒー酸及び/又はその誘導体とを含む植物がより好ましく、例えば、キク科植物のゴボウが挙げられる。イヌリン及びコーヒー酸誘導体(クロロゲン酸)を多く含むゴボウとしては、例えば、宇多金ゴボウが挙げられる。 Examples of plants that can be used in the present invention include the following. That is, examples of the plant containing inulin include chrysanthemums, katsumo, thistle, chicory, agave, dahlia, artichoke, onion, garlic, and leek. Examples of plants containing quinic acid include quina bark, coffee, apple, peach and the like. In addition, examples of plants containing caffeic acid or derivatives thereof include solanaceous, sericid, and asteraceae plants, apples, pumpkins, sweet potatoes, and coffee. In the present invention, a plant containing inulin and quinic acid, caffeic acid and / or a derivative thereof is more preferable, for example, burdock of Asteraceae plant. Examples of burdocks containing a large amount of inulin and caffeic acid derivatives (chlorogenic acid) include Utakin Burdock.
抽出物の調製は、抽出対象物である植物を、必要ならば予め水洗して異物を除いた後、これをそのままもしくは乾燥し、さらに必要ならば細切或いは粉砕した上、浸漬法、向流抽出法、水蒸気蒸留法等の常法に従って抽出溶媒と接触させることによって行うことができる。また、本発明において、超臨界抽出法を採用してもよい。 The extract is prepared by washing the plant to be extracted beforehand with water if necessary to remove foreign substances, and then leaving it as it is or drying, and further chopping or pulverizing it if necessary, followed by a dipping method or countercurrent flow. It can carry out by making it contact with an extraction solvent in accordance with conventional methods, such as an extraction method and a steam distillation method. In the present invention, a supercritical extraction method may be employed.
抽出物処理に使用する抽出溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類;エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などが挙げられ、それらは単独でもしくは二種以上混合して用いられる。本発明においては、イヌリン及びコーヒー酸又はその誘導体を高濃度に得られるという点から、極性の異なる二種の混合溶媒を使用することがより好ましい。 The extraction solvent used for the extract treatment includes water; lower alcohols such as methanol, ethanol and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol and glycerin; ethyl acetate and butyl acetate. And esters such as methyl propionate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; and hydrocarbon solvents such as n-hexane, toluene and chloroform. A mixture of two or more types is used. In the present invention, it is more preferable to use two kinds of mixed solvents having different polarities from the viewpoint that inulin and caffeic acid or a derivative thereof can be obtained at a high concentration.
抽出物の調製に当たって、抽出液のpHに特に制限はないが、一般にはpH3〜9の範囲とすることが好ましい。pHの調整は、前記した抽出溶媒中に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤や、クエン酸、塩酸、リン酸、硫酸などの酸性調整剤等を配合することによって行うことができる。 In preparing the extract, the pH of the extract is not particularly limited, but it is generally preferably in the range of pH 3-9. The pH is adjusted by blending an alkaline adjusting agent such as sodium hydroxide, sodium carbonate or potassium hydroxide, or an acidic adjusting agent such as citric acid, hydrochloric acid, phosphoric acid or sulfuric acid into the extraction solvent. be able to.
抽出温度、時間等の抽出条件は、用いる溶媒の種類やpH、或いは植物素材の大きさ等によっても異なるが、例えばメタノール又はエタノール、或いは水と低級アルコール又は多価アルコールとの混合溶媒を抽出溶媒とする浸漬法の場合であれば、抽出温度は0〜80℃の範囲である。抽出時間は、4℃の冷温抽出の場合で1時間〜7日間の範囲とするのがよく、また、40℃付近の中温抽出では、1時間〜3日間の範囲とするのがよく、70〜80℃の高温抽出の場合は、1時間〜24時間の範囲とするのがよい。浸漬法の場合、浴比は重量比で、植物素材に対して溶媒が一般に1〜200倍量、好ましくは1〜100倍量の範囲となるようにするのがよい。 Extraction conditions such as extraction temperature and time vary depending on the type and pH of the solvent used, the size of the plant material, and the like. For example, methanol or ethanol, or a mixed solvent of water and lower alcohol or polyhydric alcohol is used as the extraction solvent. In the case of the immersion method, the extraction temperature is in the range of 0 to 80 ° C. In the case of cold extraction at 4 ° C., the extraction time is preferably in the range of 1 hour to 7 days, and in the medium temperature extraction around 40 ° C., the extraction time is preferably in the range of 1 hour to 3 days. In the case of high-temperature extraction at 80 ° C., the range is preferably 1 hour to 24 hours. In the case of the immersion method, the bath ratio is a weight ratio, and the solvent is generally in the range of 1 to 200 times, preferably 1 to 100 times the amount of the plant material.
以上のようにして調製される植物抽出物は、さらに、活性炭処理、イオン交換樹脂処理、合成吸着剤、シリカゲル、及び再結晶処理のいずれか1種又は2種以上を組み合わせて、イヌリン、キナ酸、コーヒー酸及びその誘導体の少なくとも1以上を高濃度に含む抽出物に調製することでもよい。活性炭としては、松等の木、竹、椰子殻、胡桃殻等の植物質のほか、石炭質、石油質等を原材料として、それらの原材料に水蒸気や二酸化炭素、空気等のガスを使う高温炭化法等の物理的な方法や塩化亜鉛等の化学薬品を使って処理した上で加熱し、多孔質にする化学的な方法による活性化処理を施して得られる活性炭等何れを用いても良い。また、合成吸着剤としては、スチレン/ジビニルベンゼン共重合体、メタクリル酸エステル重合体等の非イオン性樹脂が挙げられる。 The plant extract prepared as described above is further combined with one or more of activated carbon treatment, ion exchange resin treatment, synthetic adsorbent, silica gel, and recrystallization treatment to produce inulin and quinic acid. Alternatively, an extract containing a high concentration of at least one of caffeic acid and derivatives thereof may be prepared. Activated carbon is not only plant materials such as pine trees, bamboo, coconut shells, walnut shells, etc., but also carbonaceous, petroleum, etc. as raw materials, and high temperature carbonization using gas such as water vapor, carbon dioxide, air etc. as those raw materials Any of activated carbon obtained by applying a physical method such as a chemical method or a chemical method such as zinc chloride and then heating and heating to a porous chemical method may be used. Examples of the synthetic adsorbent include nonionic resins such as styrene / divinylbenzene copolymer and methacrylic acid ester polymer.
以上のようにして得られる抽出物に含まれるイヌリン、キナ酸、コーヒー酸又はその誘導体の重量%は、以下の量が好ましい。本発明において、抽出物に含まれるイヌリンの固形分量は、固形分重量20〜90重量%が好ましい。また、抽出物に含まれるキナ酸、コーヒー酸又はその誘導体の固形分量は、固形分重量0.001〜5.0重量%が好ましい。また、当該抽出物を配合した毛髪化粧料中のイヌリンの量は、固形分重量0.1〜1.0重量%が好ましく、キナ酸、コーヒー酸又はその誘導体の固形分量は、固形分重量0.00001〜0.02重量%が好ましい。 The following amounts are preferable as the weight% of inulin, quinic acid, caffeic acid or a derivative thereof contained in the extract obtained as described above. In the present invention, the solid content of inulin contained in the extract is preferably 20 to 90% by weight. The solid content of quinic acid, caffeic acid or a derivative thereof contained in the extract is preferably 0.001 to 5.0% by weight of the solid content. Further, the amount of inulin in the hair cosmetic containing the extract is preferably 0.1 to 1.0% by weight of the solid content, and the solid content of quinic acid, caffeic acid or a derivative thereof is 0% by weight of the solid content. 0.0001 to 0.02% by weight is preferred.
本発明において、イヌリンとキナ酸又はコーヒー酸若しくはその誘導体とを含む場合は、毛髪化粧用中のイヌリンとキナ酸又はコーヒー酸若しくはその誘導体との相対比(重量比)は、10:1〜99:1である。 In the present invention, when inulin and quinic acid or caffeic acid or a derivative thereof are included, the relative ratio (weight ratio) between inulin and quinic acid or caffeic acid or a derivative thereof for hair cosmetics is 10: 1 to 99. : 1.
イヌリン又はその誘導体、キナ酸又はコーヒー酸若しくはその誘導体、及び本発明に係る植物抽出物は、後述するように、XVII型コラーゲン合成促進作用を有し、また、毛包幹細胞のマーカータンパク質の合成を促進することが示唆される。これらの作用により、加齢により減少する毛包幹細胞を健全な状態に維持し、毛髪サイクルの開始を促すことができる。 Inulin or a derivative thereof, quinic acid or caffeic acid or a derivative thereof, and a plant extract according to the present invention have an action of promoting collagen type XVII synthesis, as described later, and also synthesize marker proteins of hair follicle stem cells. It is suggested to promote. By these actions, hair follicle stem cells that decrease with aging can be maintained in a healthy state, and the start of the hair cycle can be promoted.
本発明に係る抽出物を毛髪化粧料(医薬部外品も含む)に配合する場合、例えば、育毛・養毛用化粧料であれば、一般的には0.00001〜5.0重量%(固形分重量%、以下同じ)であり、好ましくは、0.001〜3.0重量%である。また、シャンプー等の洗髪用化粧料であれば、一般的には0.00001〜5.0重量%(固形分重量%、以下同じ)であり、好ましくは、0.0001〜1.0重量%である。また、リンスやコンディショナーであれば、一般的には0.00001〜5.0重量%(固形分重量%、以下同じ)であり、好ましくは、0.001〜1.0重量%である。 When blending the extract according to the present invention into a hair cosmetic (including quasi-drugs), for example, if it is a hair-growth / hair-raising cosmetic, it is generally 0.00001 to 5.0% by weight ( % By solid content, the same applies hereinafter), preferably 0.001 to 3.0% by weight. Further, in the case of a hair-washing cosmetic such as shampoo, it is generally 0.00001 to 5.0% by weight (solid content% by weight, hereinafter the same), preferably 0.0001 to 1.0% by weight. It is. In the case of a rinse or a conditioner, it is generally 0.00001 to 5.0 wt% (solid content wt%, hereinafter the same), and preferably 0.001 to 1.0 wt%.
本発明に係るイヌリン、キナ酸、コーヒー酸又はそれらの誘導体、或いはそれらの少なくとも1以上の植物の抽出物を毛髪化粧料(医薬部外品も含む)に配合する際に、毛髪化粧料に用いられる他の活性成分(毛母細胞賦活剤、抗男性ホルモン剤、血行促進剤、皮脂分泌抑制剤、抗炎症剤、毛髪保護剤、毛周期の成長維持剤等)を組み合わせて配合するようにしてもよく、これによって、相乗的な育毛・養毛効果、髪質の改善効果及び頭皮の炎症予防:改善効果等を期待することもできる。 When the inulin, quinic acid, caffeic acid or derivatives thereof according to the present invention or at least one plant extract thereof is blended in hair cosmetics (including quasi-drugs), it is used for hair cosmetics. Other active ingredients (hair matrix cell activator, anti-androgen hormone agent, blood circulation promoter, sebum secretion inhibitor, anti-inflammatory agent, hair protecting agent, hair cycle growth maintaining agent, etc.) In this way, a synergistic hair-growth / hair-restoration effect, a hair quality-improving effect, and scalp inflammation prevention: an improving effect can also be expected.
例えば、育毛・養毛効果の相乗効果が期待できる成分としては、ミノキシジル、シプロテロンアセテート、ペンタデカン酸グリセリド、6−アミノベンジルプリン(サイトプリン)、アデノシン、トランス−3,4'−ジメチル3−ヒドロキシフラバノン(t−フラバノン)、センブリエキス、ヒノキチオール、感光素、パントテン酸及びその誘導体、ビタミンE及びその誘導体、ニコチン酸誘導体(ニコチン酸アミド等)、塩化カルプロニウム、女性ホルモン類(エチニルエストラジオール、エストロン等)、サリチル酸、グリチルリチン酸ジカリウム、ヒノキチオール、塩化ベンザルコニウム、イソプロピルメチルフェノール、l−メントール、塩酸ピリドキシン(ビタミンB6)、チオキソロン、カンファー、レゾルシン、タマサキツヅラフジ根の抽出物、タマサキツヅラフジから得られるビス型アルカロイド、甘草エキス、センブリエキス、マイマイ花エキス、カミツレエキス、ローヤルゼリー発酵物、ハスの種子発酵物、イチョウエキス、パルダルコ樹皮エキス、ゲンチアナエキス、オタネニンジンエキス、豆乳発酵液、黒大豆加水分解エキス、アッケシソウエキス、タケノコエキス、葛根エキス、ミツイシコンブエキス、チョウジエキス、コラーゲン、アミノ酸類、及びビタミン類等が挙げられ、それらのいずれか1種又は2種以上を配合してもよい。 For example, components that can be expected to have a synergistic effect on hair growth and nourishing include minoxidil, cyproterone acetate, pentadecanoic acid glyceride, 6-aminobenzylpurine (cytopurine), adenosine, trans-3,4'-dimethyl 3-hydroxy Flavanone (t-flavanone), assembly extract, hinokitiol, photosensitizer, pantothenic acid and its derivatives, vitamin E and its derivatives, nicotinic acid derivatives (nicotinic acid amide, etc.), carpronium chloride, female hormones (ethinylestradiol, estrone, etc.) , Salicylic acid, dipotassium glycyrrhizinate, hinokitiol, benzalkonium chloride, isopropylmethylphenol, l-menthol, pyridoxine hydrochloride (vitamin B6), thioxolone, camphor, resorcin, tamasakitsu Extract of Root, Bis-type alkaloids obtained from Shirasu, Rhizome extract, Licorice extract, Maimai flower extract, Chamomile extract, Fermented royal jelly, Fermented lotus seed, Ginkgo biloba extract, Pardarco bark extract, Gentian extract, Panax ginseng Extract, soymilk fermented liquid, black soybean hydrolysate extract, rhododendron extract, bamboo shoot extract, kudzu root extract, beetroot extract, clove extract, collagen, amino acids, vitamins, etc., any one or more of them May be blended.
特に、頭皮の炎症を抑える「グリチルリチン酸ジカリウム、甘草エキス、パルダルコ樹皮エキス又はゲンチアナエキス」、頭皮の炎症を抑える効果及び殺菌効果を有する「イソプロピルメチルフェノール」、血流促進効果を有する「タマサキツヅラフジ根エキス又はそれから得られるビス型アルカロイド」、血流促進効果及び皮脂分泌抑制効果を有する「オタネニンジンエキス」、血行促進効果を有する「センブリエキス」、皮脂の酸化抑制効果を有する「豆乳発酵液」、頭皮のバリア機能を回復させる「アッケシソウエキス」、毛髪の成長期への移行を促進する「タケノコエキス又は葛根エキス」、脱毛を抑制する「ミツイシコンブエキス」及び頭皮の乾燥を抑制する「コラーゲン」の少なくとも1以上と併用することが好ましい。 In particular, “Dipotassium glycyrrhizinate, licorice extract, Pardarco bark extract or gentian extract” that suppresses inflammation of the scalp, “Isopropylmethylphenol” that suppresses inflammation of the scalp and has a bactericidal effect, Root extract or bis-type alkaloid obtained therefrom, “Ginseng extract” having blood flow promoting effect and sebum secretion inhibiting effect, “Sembly extract” having blood circulation promoting effect, “Soy milk fermentation solution” having sebum oxidation inhibiting effect, At least of “Acanthus extract” that restores the barrier function of the scalp, “Bamboo shoot extract or kuzu root extract” that promotes the transition to the hair growth stage, “Mitsuishi kombu extract” that inhibits hair loss, and “Collagen” that inhibits scalp drying It is preferable to use in combination with one or more.
また、本発明に係る抽出物を含む毛髪化粧料(医薬部外品も含む)には、上述の成分のほかに、通常、毛髪化粧料(医薬部外品も含む)に用いられる成分、例えば油性成分、界面活性剤(合成系、天然物系)、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、キレート剤、ph調整剤、色素、香料等を必要に応じて適宜配合することができる。また、本発明に係る有効成分の有効性、特長を損なわない限り、他の生理活性成分を組み合わせて配合することも何ら差し支えない。 In addition to the above-mentioned components, hair cosmetics (including quasi-drugs) containing the extract according to the present invention usually include components used for hair cosmetics (including quasi-drugs), for example, Oily components, surfactants (synthetic and natural products), moisturizers, thickeners, antiseptics / bactericides, powder components, UV absorbers, antioxidants, chelating agents, ph adjusters, dyes, fragrances, etc. Can be appropriately blended as necessary. Moreover, as long as the effectiveness and characteristics of the active ingredient according to the present invention are not impaired, it may be combined with other physiologically active ingredients.
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボガド油、マカデミアナッツ油、ニンジン油、オタネニンジン油、ベルガモット油、植物由来スクワラン等の植物由来の油脂類;ミンク油、タートル油等の動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリン等のロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワラン等の炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、エイコセン酸等の脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコール等の高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)等の合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, as the oil component, for example, olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadow foam oil, sheer butter, tea tree oil, avocado oil, Macadamia nut oil, carrot oil, ginseng oil, bergamot oil, plant-derived oils such as squalane; animal-derived oils such as mink oil, turtle oil; waxes such as beeswax, carnauba wax, rice wax, lanolin; Hydrocarbons such as paraffin, petrolatum, paraffin wax, squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol and stearyl alcohol; myristin Isopropyl acid, palmitic acid Isopropyl, butyl oleate, 2-ethylhexyl glycerides, synthetic esters and synthetic triglycerides such as higher fatty acid octyldodecyl (octyl stearate dodecyl and the like), and the like.
界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステル等の非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩等のアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩等のカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタイン等の両性界面活性剤等を使用することができる。 Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, Anions such as polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates Surfactant; quaternary ammonium salt, primary to tertiary fatty amine salt, trialkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N, Cationic surfactants such as N-dialkylmorphonium salts and polyethylene polyamine fatty acid amide salts; N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N-alkylene Amphoteric surfactants such as ammoniocarboxybetaine and N-acylamidopropyl-N ′, N′-dimethyl-N′-β-hydroxypropylammoniosulfobetaine can be used.
乳化剤又は乳化助剤としては、酵素処理ステビア等のステビア誘導体、サポニン又はその誘導体、カゼイン又はその塩(ナトリウム等)、糖と蛋白質の複合体、ショ糖又はそのエステル、ラクトース、大豆由来の水溶性多糖、大豆由来蛋白質と多糖の複合体、ラノリン又はその誘導体、コレステロール、ステビア誘導体(ステビア酵素処理物等)、ケイ酸塩(アルミニウム、マグネシウム等)、炭酸塩(カルシウム、ナトリウム等)、サポニン及びその誘導体、レシチン及びその誘導体(水素添加レシチン等)、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀等)等を配合することもできる。 Examples of emulsifiers or emulsifiers include stevia derivatives such as enzyme-treated stevia, saponins or derivatives thereof, casein or salts thereof (sodium, etc.), sugar-protein complexes, sucrose or esters thereof, lactose, soybean-derived water-soluble Polysaccharides, soy-derived protein and polysaccharide complex, lanolin or derivatives thereof, cholesterol, stevia derivatives (stevia enzyme-treated products, etc.), silicates (aluminum, magnesium, etc.), carbonates (calcium, sodium, etc.), saponins and their Derivatives, lecithin and derivatives thereof (hydrogenated lecithin, etc.), lactic acid bacteria fermented rice, lactic acid bacteria fermented rice, lactic acid bacteria fermented cereals (wheat, legumes, millet, etc.) and the like can also be blended.
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、コンドロイチン及びその誘導体、ヘパリン及びその誘導体等)、エラスチン及びその誘導体、コラーゲン加水分解物、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、海藻抽出物、シラン根(白及)抽出物、各種アミノ酸及びそれらの誘導体が挙げられる。 Examples of the humectant include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and sugars such as trehalose, mucopolysaccharides (for example, hyaluron). Acid and derivatives thereof, chondroitin and derivatives thereof, heparin and derivatives thereof, elastin and derivatives thereof, collagen hydrolyzate, NMF related substances, lactic acid, urea, higher fatty acid octyldodecyl, seaweed extract, silane root (white and white) Examples include extracts, various amino acids, and derivatives thereof.
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;シラン根(白及)抽出物;ペクチン、ローカストビーンガム、アロエ多糖体、アルカリゲネス産生多糖体等の多糖類;キサンタンガム、トラガントガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体;ポリグルタミン酸及びその誘導体等が挙げられる。 Examples of the thickener include brown algae such as alginic acid, agar, carrageenan and fucoidan, green algae or red algae-derived components; silane root (white) extract; pectin, locust bean gum, aloe polysaccharides, alkaligenes-producing polysaccharides, etc. Polysaccharides; gums such as xanthan gum, tragacanth gum and guar gum; cellulose derivatives such as carboxymethylcellulose and hydroxyethylcellulose; synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer and acrylic acid / methacrylic acid copolymer; hyaluronic acid And its derivatives; polyglutamic acid and its derivatives.
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチル等のパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、プロパンジオール、1,2−ペンタンジオール、各種精油類、樹皮乾留物、大根発酵液、サトウキビ等の植物由来のエタノール又は1,3−ブチレングリコール等がある。 Examples of the antiseptic / bactericidal agent include urea; paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzaza chloride Plant-derived ethanol such as ruconium, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazodenyl urea), propanediol, 1,2-pentanediol, various essential oils, dry bark, radish fermented liquor, sugarcane Alternatively, there is 1,3-butylene glycol.
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビ等)のパウダー、豆類(大豆、小豆等)のパウダー等がある。 Examples of powder components include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, and cellulose. System powder, cereal (rice, wheat, corn, millet, etc.) powder, legume (soybean, red bean, etc.) powder, and the like.
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4 -Methoxybenzophenone-5-sulfonate, 4-tertiarybutyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. .
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体(例えば、ビタミンEニコチネート、ビタミンEリノレート等)等がある。 Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and its derivatives (for example, vitamin E nicotinate, vitamin E linoleate, etc.).
キレート剤としては、例えばエチレンジアミンヒドロキシエチル三酢酸三ナトリウム、エデト酸又はその塩類、グルコン酸、フィチン酸、ポリリン酸ナトリウム、メタリン酸ナトリウム、ヒドロキシエタンジホスホン酸四ナトリウムなどがある。 Examples of chelating agents include trisodium ethylenediaminehydroxyethyl triacetate, edetic acid or salts thereof, gluconic acid, phytic acid, sodium polyphosphate, sodium metaphosphate, tetrasodium hydroxyethanediphosphonate, and the like.
pH調整剤としては、例えばクエン酸又はその塩類、乳酸又はその塩類、グリコール酸、コハク酸、塩酸、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、水酸化ナトリウム、水酸化カリウムなどがある。 Examples of the pH adjuster include citric acid or a salt thereof, lactic acid or a salt thereof, glycolic acid, succinic acid, hydrochloric acid, monoethanolamine, diethanolamine, triethanolamine, sodium hydroxide, potassium hydroxide and the like.
生理活性成分としては、例えば、胎盤抽出液、ソウハクヒ抽出物、ユキノシタ抽出物、シソ抽出物、米糠抽出物又はその加水分解物、白芥子抽出物又はその加水分解物、白芥子の発酵物、シャクヤク抽出物又はその加水分解物、ムラサキシキブ抽出物、ハス種子抽出物又はその加水分解物、党参抽出物又はその加水分解物、ハトムギ加水分解物、ハトムギ種子発酵物、酒粕抽出物又はそれに含まれるセラミド、酒粕発酵物、パンダヌス・アマリリフォリウス(Pandanus amaryllifolius Roxb.)抽出物、アルカンジェリシア・フラバ(Arcangelicia flava Merrilli)抽出物、イネの葉の抽出物又はその加水分解物、ナス(ベルガモット、長ナス、賀茂ナス、米ナス等)抽出物又はその加水分解物、アンズ果実の抽出物、カタメンキリンサイ等の海藻の抽出物、クラゲ水、米抽出物又はその加水分解物、米醗酵エキス、発芽米抽出物又はその加水分解物、発芽米発酵物、ダマスクバラの花の抽出物、リノール酸及びその誘導体もしくは抽出物(例えばリポソーム化リノール酸等)、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、グリチルレチン酸及びその誘導体、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、アラントイン、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ニンジン抽出物、紅参抽出物、ヘチマ抽出物、アナアオサ抽出物、モモ抽出物、桃仁抽出物、キウイ抽出物、ヒマワリ種子又は芽の抽出物、ジュアゼイロ(Zizyphus joazeiro)抽出物、萱草(デイリリー)抽出物または発酵物、ハイビスカスの花抽出物または発酵物、ハゴロモグサ抽出物、チェリモヤ抽出物、マンゴー抽出物、マンゴスチン抽出物、フノリ抽出物、烏龍茶抽出物、紅富貴抽出物、紫蘭抽出物、山椒果皮又は種皮の抽出物または加水分解物、ベニバナ花抽出物、カサブランカ抽出物、甘藷抽出物又はその発酵物、グアバ葉抽出物、ドクダミ抽出物、晩白柚抽出物、アロエ抽出物、イチジク花抽出物、リンゴ抽出物等がある。 Examples of the physiologically active component include placenta extract, Sakuhakuhi extract, Yukinoshita extract, perilla extract, rice bran extract or hydrolyzate thereof, white coconut extract or hydrolyzate thereof, fermented white coconut, peony Extract or hydrolyzate thereof, Murasakixikib extract, Lotus seed extract or hydrolyzate thereof, Participant extract or hydrolyzate thereof, pearl barley hydrolysate, barley seed fermented product, sake lees extract or ceramide contained therein Fermented sake lees, Pandanus amaryllifolius Roxb. Extract, Arcangelicia flava Merrilli extract, rice leaf extract or hydrolyzate thereof, eggplant (bergamot, long eggplant, Kamo eggplant, rice eggplant, etc.) extract or its hydrolyzate, apricot fruit extract, seaweed extract such as catamen giraffe, jellyfish Water, rice extract or hydrolyzate thereof, rice fermented extract, germinated rice extract or hydrolyzate thereof, germinated rice fermented product, damask rose flower extract, linoleic acid and its derivatives or extracts (eg, liposome formation) Linoleic acid etc.), animal or fish derived collagen and derivatives thereof, elastin and derivatives thereof, glycyrrhetinic acid and derivatives thereof, t-cycloamino acid derivatives, vitamin A and derivatives thereof, allantoin, diisopropylamine dichloroacetate, γ-amino-β -Hydroxybutyric acid, carrot extract, red ginseng extract, loofah extract, anaaosa extract, peach extract, peach extract, kiwi extract, sunflower seed or bud extract, Zizyphus joazeiro extract, camellia (Daily) Extract or fermented product, Hibiscus flower extract or fermented product, Hago Lomogusa extract, cherimoya extract, mango extract, mangosteen extract, funori extract, oolong tea extract, red rich extract, purple orchid extract, extract of yam peel or seed coat or hydrolysate, safflower flower extract, Examples include Casablanca extract, sweet potato extract or fermented product thereof, guava leaf extract, dokudami extract, evening birch extract, aloe extract, fig flower extract, apple extract and the like.
次に、製造例、処方例及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下において、部はすべて重量部を、また%はすべて重量%を意味する。 Next, the present invention will be described more specifically with reference to production examples, formulation examples, and test examples, but the present invention is not limited thereto. In the following, all parts are parts by weight, and all percentages are% by weight.
イヌリン又はその誘導体、及びコーヒー酸の誘導体(クロロゲン酸)を含む植物抽出物として、キク科ゴボウ属に属するゴボウの抽出物の製造例を以下に示す。 An example of producing an extract of burdock belonging to the genus Burdaceae as a plant extract containing inulin or a derivative thereof and a derivative of caffeic acid (chlorogenic acid) is shown below.
製造例1.ゴボウの抽出物の調製(1)
ゴボウの根の乾燥物10gに精製水を50gとエタノール50gとを添加し、50℃で浸漬した。これをろ過し、褐色透明のゴボウ根抽出物溶液90g得た(固形分濃度1.54%)。得られた抽出物溶液を濃縮して、濃縮液13.5gを得た。
Production Example 1 Preparation of burdock extract (1)
Purified water (50 g) and ethanol (50 g) were added to 10 g of dried burdock roots and immersed at 50 ° C. This was filtered to obtain 90 g of a brown transparent burdock root extract solution (solid content concentration 1.54%). The obtained extract solution was concentrated to obtain 13.5 g of a concentrated solution.
製造例2.ゴボウの抽出物の調製(2)
ゴボウの根の乾燥物10gに精製水50gと1,3−ブチレングリコール50gを添加し、40℃で浸漬した。これをろ過し、褐色透明のゴボウ根抽出物90gを得た(固形分濃度1.62g)。得られた抽出物溶液を濃縮して、濃縮液13.5gを得た。
Production Example 2 Preparation of burdock extract (2)
Purified water (50 g) and 1,3-butylene glycol (50 g) were added to 10 g of dried burdock root and immersed at 40 ° C. This was filtered to obtain 90 g of brown transparent burdock root extract (solid content concentration 1.62 g). The obtained extract solution was concentrated to obtain 13.5 g of a concentrated solution.
製造例3.ゴボウの抽出物の調製(3)
ゴボウの根の乾燥物10gに精製水50gと1,2−ペンタンジオール50gを添加し、40℃で浸漬した。これをろ過し、褐色透明のゴボウ根抽出物90gを得た(固形分濃度1.59g)。得られた抽出物溶液を濃縮して、濃縮液13.5gを得た。
Production Example 3 Preparation of burdock extract (3)
Purified water (50 g) and 1,2-pentanediol (50 g) were added to 10 g of dried burdock root and immersed at 40 ° C. This was filtered to obtain 90 g of a brown transparent burdock root extract (solid content concentration: 1.59 g). The obtained extract solution was concentrated to obtain 13.5 g of a concentrated solution.
製造例1〜3の抽出物に、イヌリン及びクロロゲン酸が含まれることを、常法により確認した。すなわち、クロロゲン酸の検出についてはフォーリン・チオカルト法(比色法)を用いて確認し、イヌリンについては、還元糖を検出するDNS法(比色法)を用いて確認した。 It was confirmed by a conventional method that the extracts of Production Examples 1 to 3 contain inulin and chlorogenic acid. That is, the detection of chlorogenic acid was confirmed by using the foreign thiocult method (colorimetric method), and the inulin was confirmed by using the DNS method (colorimetric method) for detecting reducing sugars.
なお、本発明に係る植物抽出物は、上記製造例に限るものではなく、イヌリン、キナ酸或いはコーヒー酸又はその誘導体をそれぞれ含む植物の抽出物を組み合わせることでもよい。例えば、ゴボウに代えて、製造例1〜3に記載のゴボウに代えて、菊芋、コーヒー種子、アーティチョーク、リンゴ果実等を用いて、抽出操作を行い、それら抽出物を併用することでもよい。 In addition, the plant extract which concerns on this invention is not restricted to the said manufacture example, You may combine the extract of the plant each containing inulin, quinic acid, caffeic acid, or its derivative (s). For example, instead of the burdock, instead of the burdock described in Production Examples 1 to 3, an extraction operation may be performed using chrysanthemums, coffee seeds, artichokes, apple fruits, and the like, and these extracts may be used in combination.
試験例1.XVII型コラーゲン産生促進の評価
正常ヒト表皮細胞 (NHEK) をHumedia-KG2培地[クラボウ社製]を添加した96穴マイクロプレートに8×103個/穴播種し、37℃,5.0%CO2の条件下に1日間プレ培養した後、表1に示す試料溶液1〜7を所定の濃度で含むように調整したHumedeia-KG2培地を添加し、同条件でさらに2日間培養した。ここで、試料溶液6,7に係る抽出物の濃度は、培地の量に対して溶液として終濃度が0.5%,1.0%となるように調整した。その後、XVII型コラーゲン抗体を用いた免疫的検出を行った。すなわち、PBS(-)洗浄後、15%中性緩衝ホルマリン液を用いて細胞を30分間処理して固定し、その後、0.5%Triton X-100溶液で1時間浸透処理と、5倍希釈ブロッキングワンP(ナカライテスク社)溶液で2時間処理によるブロッキングを行った後、XVII型コラーゲン抗体を添加し、室温で2時間静置した。その後、PBS(-)で洗浄し、蛍光ラベルした二次抗体を添加してさらに暗所で一定時間静置した。PBS(-)洗浄後、蛍光強度の測定を行った。まず、二次抗体の蛍光ラベル(Alexa Fluor594)をEx=544nm、Em=590nmで測定し(蛍光マイクロプレートリーダー[フルオロスキャンアセント、Thermo Fisher Scientific社製])、その後、Hoechst33342によるDNA染色を行い、Ex=355nm、Em=460nmの測定を行った。それぞれの試験区のAlexa Fluor594の蛍光強度をHoechst33342の蛍光強度で割ることで、XVII型コラーゲンの生成度合いを求めた。また、試料溶液に代えて50%1,3−ブチレングリコール溶液(50%BG溶液)又はPBS、DMSOを添加した試料無添加(対照)のコントロール区についても上記と同様の操作を行い、コントロール区で得られたXVII型コラーゲン生成度合いに対する各試料添加時のXVII型コラーゲン生成度合いの相対値を求め、XVII型コラーゲン生成率(%)とした。
Test Example 1 Evaluation of type XVII collagen production promotion Normal human epidermal cells (NHEK) were seeded at 8 × 10 3 cells / hole in a 96-well microplate supplemented with Humedia-KG2 medium [manufactured by Kurabo Industries, Inc.], 37 ° C., 5.0% CO After pre-culturing for 1 day under the conditions of 2 , the Humedeia-KG2 medium prepared so as to contain the sample solutions 1 to 7 shown in Table 1 at a predetermined concentration was added, and further cultured under the same conditions for 2 days. Here, the density | concentration of the extract which concerns on the sample solutions 6 and 7 was adjusted so that final concentration might become 0.5% and 1.0% as a solution with respect to the quantity of a culture medium. Thereafter, immunodetection using a type XVII collagen antibody was performed. That is, after washing with PBS (-), cells were fixed by treatment with 15% neutral buffered formalin solution for 30 minutes, then permeabilized with 0.5% Triton X-100 solution for 1 hour, and 5-fold diluted blocking one. After blocking by treatment with P (Nacalai Tesque) solution for 2 hours, type XVII collagen antibody was added and allowed to stand at room temperature for 2 hours. Thereafter, the plate was washed with PBS (−), a fluorescently labeled secondary antibody was added, and the mixture was further allowed to stand in the dark for a certain time. After washing with PBS (-), fluorescence intensity was measured. First, the fluorescent label (Alexa Fluor594) of the secondary antibody was measured at Ex = 544 nm and Em = 590 nm (fluorescence microplate reader [Fluoroscan Ascent, manufactured by Thermo Fisher Scientific)], and then DNA staining with Hoechst33342 was performed. Measurements were performed at Ex = 355 nm and Em = 460 nm. The degree of XVII collagen production was determined by dividing the fluorescence intensity of Alexa Fluor594 in each test group by the fluorescence intensity of Hoechst33342. In addition, the same procedure as above was performed for the control group without the sample solution (control) to which 50% 1,3-butylene glycol solution (50% BG solution) or PBS or DMSO was added instead of the sample solution. A relative value of the degree of type XVII collagen formation at the time of each sample addition to the degree of type XVII collagen production obtained in the above was determined and used as the XVII type collagen production rate (%).
[表1]
本発明の評価試験で用いる試料溶液を表1に示す。
[Table 1]
Table 1 shows sample solutions used in the evaluation test of the present invention.
試験例1の結果を表2に示す。
[表2]
The results of Test Example 1 are shown in Table 2.
[Table 2]
表2に示すように、本発明に係る有効成分(試料溶液1〜7)は、表皮細胞におけるXVII型コラーゲン産生促進効果を有することが確認された。XVII型コラーゲンは、毛髪サイクルの開始に重要な役割を果たす毛包幹細胞をバルジ領域に保持するものであることから、本発明によれば、当該コラーゲンの産生を促進することで、毛髪サイクルを健全な状態に維持して、薄毛、脱毛を予防、改善することができる。 As shown in Table 2, it was confirmed that the active ingredients (sample solutions 1 to 7) according to the present invention have an XVII collagen production promoting effect in epidermal cells. Since type XVII collagen retains hair follicle stem cells that play an important role in the initiation of the hair cycle in the bulge region, according to the present invention, the production of the collagen promotes the hair cycle to be healthy. It is possible to prevent and improve thinning and hair loss while maintaining a stable state.
試験例2.XVII型コラーゲン遺伝子発現促進効果の評価
正常ヒト表皮細胞 (NHEK) をHumedia-KG2培地[クラボウ社製]を添加した6穴プレートに6×105個/穴播種し、5.0%CO2、飽和水蒸気下、37℃で培養した。24時間培養後、表1に示す試料溶液1〜7を添加して培養した。ここで、試料溶液6,7に係る抽出物の濃度は、培地量に対する溶液としての終濃度が0.5%,1.0%となるように調整した。また、比較対照として、試料溶液に代えて、50%BG溶液(1.0%) を添加したコントロール区を設定した。24時間培養後、それぞれの試験区及びコントロール区の細胞をTrizol試薬(Invitrogen社製)1mLで回収した。回収した細胞に対してクロロホルム(和光純薬工業社製)200μL添加して撹拌混合し遠心分離機(TOMY社製/MX-160)で15,000rpm、4℃の条件下で15分間遠心分離した後、水層のみを400μL分取した。回収した水層にイソプロパノール(和光純薬工業社製)500μLを添加して撹拌混合し、15,000rpm、4℃の条件下で15分間遠心分離してtotalRNAの沈殿物を得た。totalRNAに75%エタノールを1mL添加して撹拌して洗浄し、15,000rpm、4℃条件下で15分間遠心分離して沈殿を回収した。回収したtotal RNAを所定のキット(PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time)[タカラバイオ社製])を用いて逆転写反応し、cDNAを合成した。合成したcDNAをサンプルとして、Thermal Cycler Dice(登録商標)Real Time System Single(タカラバイオ社製)、及びSYBR(登録商標)Premix Ex TaqTM II(Perfect Real Time)[タカラバイオ社製]を用いて、XVII型コラーゲン遺伝子の発現と、内部標準物質β-actin遺伝子の発現の検出を行った。ここで、β-actinは、ハウスキーピング遺伝子(多くの組織や細胞中に共通して一定量発現する遺伝子であって、常に発現され,細胞の維持,増殖に不可欠な遺伝子である)の一つであり、発現量が常に一定とされていることから、PCRの実験では内部標準として用いられるものである。試験結果は、β-actin遺伝子の発現量を一定とした場合の、それぞれの試験区での各遺伝子の発現量を比較した。本試験系においては、コントロール区のXVII型コラーゲンの遺伝子の発現量を100としたときの他の試験区でのXVII型コラーゲンの遺伝子の発現量の相対値を求めた。
Test Example 2 Evaluation of XVII collagen gene expression promoting effect Normal human epidermal cells (NHEK) were seeded at 6 × 10 5 cells / hole in a 6-well plate supplemented with Humedia-KG2 medium [manufactured by Kurabo Industries, Ltd.], 5.0% CO 2, Culturing was performed at 37 ° C. under saturated steam. After culturing for 24 hours, sample solutions 1 to 7 shown in Table 1 were added and cultured. Here, the density | concentration of the extract which concerns on the sample solutions 6 and 7 was adjusted so that the final density | concentration as a solution with respect to the culture medium amount might be 0.5% and 1.0%. Further, as a control for comparison, a control group to which a 50% BG solution (1.0%) was added instead of the sample solution was set. After culturing for 24 hours, the cells in each test group and control group were collected with 1 mL of Trizol reagent (Invitrogen). 200 μL of chloroform (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the collected cells, mixed by stirring, and centrifuged at 15,000 rpm, 4 ° C. for 15 minutes using a centrifuge (TOMY / MX-160). Thereafter, 400 μL of the aqueous layer alone was collected. To the recovered aqueous layer, 500 μL of isopropanol (manufactured by Wako Pure Chemical Industries, Ltd.) was added, mixed with stirring, and centrifuged at 15,000 rpm, 4 ° C. for 15 minutes to obtain a total RNA precipitate. 1 mL of 75% ethanol was added to totalRNA, stirred and washed, and centrifuged at 15,000 rpm and 4 ° C. for 15 minutes to collect a precipitate. The recovered total RNA was subjected to a reverse transcription reaction using a predetermined kit (PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time) [manufactured by Takara Bio Inc.]) to synthesize cDNA. Using the synthesized cDNA as a sample, Thermal Cycler Dice (registered trademark) Real Time System Single (manufactured by Takara Bio Inc.), and SYBR (registered trademark) Premix Ex TaqTM II (Perfect Real Time) [manufactured by Takara Bio Inc.] Expression of type XVII collagen gene and expression of internal standard β-actin gene were detected. Here, β-actin is one of the housekeeping genes (a gene that is expressed in a certain amount in common in many tissues and cells and is always expressed and essential for cell maintenance and proliferation). Since the expression level is always constant, it is used as an internal standard in PCR experiments. As a test result, the expression level of each gene in each test section was compared when the expression level of β-actin gene was constant. In this test system, the relative value of the expression level of the XVII collagen gene in the other test plots when the expression level of the XVII collagen gene in the control plot was set to 100 was determined.
試験例2の結果を表3に示す。
[表3]
The results of Test Example 2 are shown in Table 3.
[Table 3]
表3に示すように、本発明に係る有効成分(試料溶液1〜7)は、表皮細胞におけるXVII型コラーゲン遺伝子の発現を亢進する効果を有することが確認された。 As shown in Table 3, it was confirmed that the active ingredients (sample solutions 1 to 7) according to the present invention have an effect of enhancing the expression of the type XVII collagen gene in epidermal cells.
試験例3.毛包外毛根鞘細胞におけるXVII型コラーゲン遺伝子発現促進効果の評価
ヒト毛包外毛根鞘細胞(HHORSC)を、MSCM培地[ScienCell Research Laboratories社製]を添加した穴プレートに3×105個/穴播種し、5.0%CO2、飽和水蒸気下、37℃で培養した。24時間培養後、表1に示す試料溶液5,7を添加して培養した。ここで、試料溶液7に係る抽出物の濃度は、培地量に対する溶液としての終濃度が1.0%となるように調整した。また、比較対照として、試料溶液に代えて、50%BG溶液 (1.0%) を添加したコントロール区を設定した。24時間培養後、それぞれの試験区及びコントロール区の細胞をTrizol試薬(Invitrogen社製)1mLで回収した。回収した細胞に対してクロロホルム(和光純薬工業社製)200μL添加して撹拌混合し遠心分離機(TOMY社製/MX-160)で15,000rpm、4℃の条件下で15分間遠心分離した後、水層のみを400μL分取した。回収した水層にイソプロパノール(和光純薬工業社製)500μLを添加して撹拌混合し、15,000rpm、4℃の条件下で15分間遠心分離してtotalRNAの沈殿物を得た。totalRNAに75%エタノールを1mL添加して撹拌して洗浄し、15,000rpm、4℃条件下で15分間遠心分離して沈殿を回収した。回収したtotal RNAを所定のキット(PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time)[タカラバイオ社製])を用いて逆転写反応し、cDNAを合成した。合成したcDNAをサンプルとして、Thermal Cycler Dice(登録商標)Real Time System Single[タカラバイオ社製]、及びSYBR(登録商標)Premix Ex TaqTM II(Perfect Real Time)[タカラバイオ社製]を用いて、XVII型コラーゲン遺伝子の発現と、内部標準物質β-actin遺伝子の発現の検出を行った。試験結果は、β‐actin遺伝子の発現量を一定とした場合の、それぞれの試験区でのXVII型コラーゲン遺伝子の発現量を比較した。本試験系においては、コントロール区のXVII型コラーゲン遺伝子の発現量を100としたときの他の試験区でのXVII型コラーゲン遺伝子の発現量の相対値を求めた。
Test Example 3 Evaluation of collagen XVII collagen gene expression promoting effect in hair follicular sheath cells 3 × 10 5 cells / hole in human hair follicle sheath cells (HHORSC) added to MSCM medium [ScienCell Research Laboratories] The seeds were seeded and cultured at 37 ° C. under 5.0% CO 2 and saturated steam. After culturing for 24 hours, sample solutions 5 and 7 shown in Table 1 were added and cultured. Here, the density | concentration of the extract which concerns on the sample solution 7 was adjusted so that the final concentration as a solution with respect to the amount of culture media might be 1.0%. Further, as a comparative control, a control group to which a 50% BG solution (1.0%) was added instead of the sample solution was set. After culturing for 24 hours, the cells in each test group and control group were collected with 1 mL of Trizol reagent (Invitrogen). 200 μL of chloroform (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the collected cells, mixed by stirring, and centrifuged at 15,000 rpm, 4 ° C. for 15 minutes using a centrifuge (TOMY / MX-160). Thereafter, 400 μL of the aqueous layer alone was collected. To the recovered aqueous layer, 500 μL of isopropanol (manufactured by Wako Pure Chemical Industries, Ltd.) was added, mixed with stirring, and centrifuged at 15,000 rpm, 4 ° C. for 15 minutes to obtain a total RNA precipitate. 1 mL of 75% ethanol was added to totalRNA, stirred and washed, and centrifuged at 15,000 rpm and 4 ° C. for 15 minutes to collect a precipitate. The recovered total RNA was subjected to reverse transcription reaction using a predetermined kit (PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time) [manufactured by Takara Bio Inc.]) to synthesize cDNA. Using the synthesized cDNA as a sample, Thermal Cycler Dice (registered trademark) Real Time System Single (manufactured by Takara Bio Inc.) and SYBR (registered trademark) Premix Ex TaqTM II (Perfect Real Time) (manufactured by Takara Bio Inc.) Expression of type XVII collagen gene and expression of internal standard β-actin gene were detected. As a test result, the expression level of the type XVII collagen gene in each test section was compared when the expression level of the β-actin gene was constant. In this test system, the relative value of the expression level of the type XVII collagen gene in the other test plots when the expression level of the type XVII collagen gene in the control plot was set to 100 was determined.
試験例3の結果を表4に示す。
[表4]
The results of Test Example 3 are shown in Table 4.
[Table 4]
表4に示すように、本発明に係る有効成分(試料溶液5,7)は、毛包外毛根鞘細胞におけるXVII型コラーゲン遺伝子の発現を亢進する効果を有することが確認された。 As shown in Table 4, it was confirmed that the active ingredients (sample solutions 5 and 7) according to the present invention have the effect of enhancing the expression of the type XVII collagen gene in the hair follicle root sheath cells.
試験例4.毛包幹細胞増殖促進効果の評価
頭皮より抜毛した毛包の毛乳頭細胞(Dermal sheath)を除去し、トリプシン処理した後、トリプシン阻害剤で反応を停止し、コラーゲンコーティングを行った培養皿に移し、Humedia -KG2を用いて培養した。培養1日後、表1に示す試料溶液5,7を含むHumedeia-KG2培地を添加し、同条件でさらに3日間培養した。ここで、試料溶液7に係る抽出物の濃度は、培地量に対する溶液としての終濃度が1.0%となるように調整した。3日培養後、毛包幹細胞マーカータンパク質である「CD34タンパク質」の抗体を用いた免疫的検出を行った。すなわち、PBS(-)洗浄後、15%中性緩衝ホルマリン液を用いて培養細胞を30分処理することで固定し、0.5%Triton X-100溶液で1時間浸透処理、5倍希釈ブロッキングワンP(ナカライテスク社)溶液で2時間処理することでブロッキングを行った後、CD34抗体を添加し、冷温暗室で一晩静置した。一晩静置後、PBS(-)で洗浄し、蛍光ラベルした二次抗体を添加してさらに暗所で一定時間静置した。一定時間静置後、PBS(-)で洗浄し、蛍光観察を行った。蛍光観察で得られた画像をCS Analyzer ver 3.0 (ATTO社) を用いて輝度値を測定した。試料溶液に代えて50%BG溶液を添加した試料無添加(対照)のコントロール区についても上記と同様の操作を行い、コントロール区の輝度値に対する各試料添加時の輝度値の相対値を求め、CD34生成率(%)とした。
Test Example 4 Evaluation of hair follicle stem cell growth promoting effect Remove hair follicle dermal papilla cells (Dermal sheath) from the scalp, trypsinize, stop reaction with trypsin inhibitor, transfer to collagen-coated culture dish, Cultured using Humedia-KG2. One day after the culture, a Humedeia-KG2 medium containing the sample solutions 5 and 7 shown in Table 1 was added, and further cultured under the same conditions for 3 days. Here, the density | concentration of the extract which concerns on the sample solution 7 was adjusted so that the final concentration as a solution with respect to the amount of culture media might be 1.0%. After culturing for 3 days, immunodetection was performed using an antibody of “CD34 protein” which is a hair follicle stem cell marker protein. That is, after washing with PBS (-), the cultured cells were fixed for 30 minutes using a 15% neutral buffered formalin solution, then permeabilized with 0.5% Triton X-100 solution for 1 hour, and 5-fold diluted blocking. After blocking with a one-P (Nacalai Tesque) solution for 2 hours, the CD34 antibody was added and allowed to stand overnight in a cool and warm dark room. After standing overnight, the plate was washed with PBS (−), a fluorescently labeled secondary antibody was added, and the mixture was further left standing in the dark for a certain time. After standing for a certain period of time, it was washed with PBS (−), and fluorescence observation was performed. The brightness value of the image obtained by fluorescence observation was measured using CS Analyzer ver 3.0 (ATTO). For the control group with no sample (control) added with 50% BG solution instead of the sample solution, the same operation as described above was performed, and the relative value of the luminance value at the time of each sample addition with respect to the luminance value of the control group was determined. CD34 production rate (%).
試験例4の結果を表5に示す。
[表5]
The results of Test Example 4 are shown in Table 5.
[Table 5]
表5に示す通り、本発明に係る有効成分(試料溶液5,7)は、毛包幹細胞の増殖を促進することが示唆された。 As shown in Table 5, it was suggested that the active ingredients (sample solutions 5 and 7) according to the present invention promote the proliferation of hair follicle stem cells.
試験例5.毛髪サイクルの正常化の評価試験
被験者20人を10人毎のグループに分け、各被験者の両側頭部1cm×1cmの髪を刈り取り、それぞれを試験部位としてマイクロスコープ(Dino-Lite:サンコー株式会社)にて写真を撮影した。3日後、各試験部位について写真を撮影し、休止期の毛髪の数を画像解析によって確認した。その後、側頭部の試験部位の一方に表1に示す試料溶液5,7を3ヵ月間、1日2回塗布し、他方にコントロール溶液である「PBS(-)溶液」を同様に塗布した。3ヵ月後、試験部位の写真をマイクロスコープにて撮影し、試料溶液の塗布前と塗布後の休止期の毛髪を計測した。
Test Example 5. Evaluation test for normalization of hair cycle 20 subjects were divided into groups of 10 people, and each subject's head 1cm x 1cm hair was cut, and each was used as a test site for a microscope (Dino-Lite: Sanko Corporation) I took a photo at Three days later, photographs were taken for each test site, and the number of resting hairs was confirmed by image analysis. Thereafter, the sample solutions 5 and 7 shown in Table 1 were applied twice a day for 3 months to one of the test sites on the temporal region, and the “PBS (−) solution” as a control solution was similarly applied to the other. . Three months later, a photograph of the test site was taken with a microscope, and the resting hair before and after application of the sample solution was measured.
試験の結果を以下のとおり評価した。
(1)++:休止期の毛髪の数が減少した。
(2)+ :休止期の毛髪の数に変化がなかった。
(3)− :休止期の毛髪の数が増加した。
The test results were evaluated as follows.
(1) ++: The number of resting hairs decreased.
(2) +: There was no change in the number of hairs in the rest period.
(3)-: The number of resting hairs increased.
試験例5の結果を表6に示す。
[表6]
The results of Test Example 5 are shown in Table 6.
[Table 6]
表6に示す通り、本発明に係る有効成分(試料溶液5,7)の塗布により、被験者における休止期の毛髪の数が減少した。これにより、本発明は毛髪サイクルを正常化することが確認された。 As shown in Table 6, application of the active ingredients (sample solutions 5 and 7) according to the present invention reduced the number of resting hairs in the subjects. Thereby, it was confirmed that this invention normalizes a hair cycle.
試験例6.育毛・養毛効果に関するモニターテスト
表7,8に示す処方例1〜8及び比較例1の育毛料を用いて、モニター試験を行った。脱毛症患者である被験者(30〜65歳の男性)を5名毎のグループを分け、当該被験者を対象として、処方例1〜8及び比較例1の各育毛料を頭部に1日2回連続3か月間塗布した後、毛髪の増加について、以下の判定基準に基づき評価を行った。毛髪の増加度は、頭皮及び毛髪の状態を写真撮影したものを用いて評価した。
Test Example 6. Monitor Test Regarding Hair Growth / Hair Nourishing Effect A monitor test was conducted using the hair growth materials of Formulation Examples 1 to 8 and Comparative Example 1 shown in Tables 7 and 8. Divide subjects (30-65-year-old men) who are alopecia patients into groups of 5 people, and each hair growth material of Prescription Examples 1-8 and Comparative Example 1 is applied to the head twice a day. After application for 3 consecutive months, the increase in hair was evaluated based on the following criteria. The degree of increase in hair was evaluated using a photograph of the state of the scalp and hair.
[表7]
[Table 7]
[表8]
[Table 8]
[評価基準]
++:試験開始前と比較して毛髪の増加が確認された。
+ :試験開始前と比較して変化は確認されなかった。
− :試験開始前より毛髪の減少が確認された。
[Evaluation criteria]
++: Increased hair was confirmed compared to before the start of the test.
+: No change was confirmed compared to before the start of the test.
-: A decrease in hair was confirmed before the start of the test.
試験例6の結果を表9に示す。
[表9]
The results of Test Example 6 are shown in Table 9.
[Table 9]
表9に示す通り、本発明によれば、すぐれた育毛・養毛効果を有する育毛料を提供することができる。 As shown in Table 9, according to the present invention, it is possible to provide a hair-growth material having an excellent hair-growth / hair-growth effect.
表1に示す処方例以外の処方例も以下に示す。
処方例9.育毛料
[成分] 部
l−メントール 0.8
アデノシン 1.0
製造例1の抽出物 2.0
1,3−ブチレングリコール 10.0
フェノキシエタノール 0.2
エタノール 20.0
精製水 全量が100部となる量
上記の成分を十分攪拌混合して育毛料を得た。
Prescription examples other than the prescription examples shown in Table 1 are also shown below.
Formulation Example 9 Hair restorer [ingredient] part l-menthol 0.8
Adenosine 1.0
Extract of Production Example 1 2.0
1,3-butylene glycol 10.0
Phenoxyethanol 0.2
Ethanol 20.0
The amount in which the total amount of purified water is 100 parts The above ingredients were sufficiently stirred and mixed to obtain a hair restorer.
処方例10.育毛料
処方例9の成分中、アデノシンに代えて、ミノキシジルを用いるほかは処方例9と同様にして育毛料を得た。
Formulation Example 10 Hair growth material A hair growth material was obtained in the same manner as in Formulation Example 9 except that minoxidil was used instead of adenosine in the ingredients of Formulation Example 9.
処方例11.育毛料
処方例9の成分中、アデノシンに代えて6−ベンジルアミノプリンを用いるほかは処方例9と同様にして育毛料を得た。
Formulation Example 11 Hair growth material A hair growth material was obtained in the same manner as in Formulation Example 9 except that 6-benzylaminopurine was used instead of adenosine in the components of Formulation Example 9.
処方例12.育毛料
[成分] 部
グリチルリチン酸ジカリウム 0.1
l−メントール 0.1
製造例1の抽出物 1.0
大豆レシチン 0.2
1,3−ブチレングリコール 10.0
エタノール 20.0
タケノコ皮エキス 3.0
褐藻エキス 3.0
アッケシソウエキス 3.0
ゲンチアナエキス 3.0
アマモエキス 3.0
精製水 全量が100部となる量
Formulation Example 12. Hair restorer [ingredient] Part Potassium glycyrrhizinate
l-Menthol 0.1
Extract of Production Example 1 1.0
Soy lecithin 0.2
1,3-butylene glycol 10.0
Ethanol 20.0
Bamboo shoot extract 3.0
Brown algae extract 3.0
Hamcho Extract 3.0
Gentian extract 3.0
Amamo extract 3.0
Amount of purified water totaling 100 parts
処方例13.育毛料
処方例10において、タケノコエキスに代えて葛根エキスを用い、ゲンチアナエキスに代えてパウダルコ樹皮エキスを用いる他は、処方例10と同様にして育毛料を得た。
Formulation Example 13 Hair-growth In Formulation Example 10, hair-growth was obtained in the same manner as in Formulation Example 10 except that the kuzu-root extract was used instead of the bamboo shoot extract and the powdery bark extract was used instead of the gentian extract.
処方例14.育毛料
処方例10において、アマモエキスに代えて黒大豆加水分解エキスを用い、アッケシソウエキスに代えて豆乳発酵液を用いる他は、処方例10と同様にして育毛料を得た。
Formulation Example 14. Hair restorer In Formulation Example 10, a hair restorer was obtained in the same manner as in Formulation Example 10, except that a hydrolyzed black soybean extract was used instead of the eel extract and a soymilk fermented liquor was used instead of the extract of Hamcho.
処方例15.ヘアークリーム
[成分] 部
流動パラフィン 15.0
ワセリン 15.0
サラシミツロウ 2.0
製造例1の抽出物 1.0
褐藻エキス 0.3
カルボキシビニルポリマー 0.1
キサンタンガム 0.1
グリセリン 5.0
1、3−ブチレングリコール 2.0
ポリオキシエチレン硬化ヒマシ油 3.0
キレート剤 0.1
防腐剤 0.1
香料 0.1
色素 0.01
精製水 全量が100部となる量
Formulation Example 15. Hair cream [ingredient] part liquid paraffin 15.0
Vaseline 15.0
Sara honey bee 2.0
Extract of Production Example 1 1.0
Brown algae extract 0.3
Carboxyvinyl polymer 0.1
Xanthan gum 0.1
Glycerin 5.0
1,3-butylene glycol 2.0
Polyoxyethylene hydrogenated castor oil 3.0
Chelating agent 0.1
Preservative 0.1
Fragrance 0.1
Dye 0.01
Amount of purified water totaling 100 parts
処方例16.ヘアシャンプー
[成分] 部
N−ヤシ油脂肪酸メチルタウリンナトリウム 10.0
ポリオキシエチレン(3)アルキルエーテル硫酸ナトリウム 20.0
ラウリルジメチルアミノ酢酸ベタイン 10.0
ヤシ油脂肪酸ジエタノールアミド 4.0
メチルパラベン 0.1
クエン酸 0.1
製造例1の抽出物 2.0
コラーゲン 5.0
アマモエキス 5.0
黒大豆加水分解液 5.0
アッケシソウエキス 5.0
パウダルコ樹皮エキス 5.0
葛根エキス 5.0
1,3−ブチレングリコール 2.0
精製水 全量が100部となる量
Formulation Example 16. Hair shampoo [ingredient] part N-coconut oil fatty acid methyl taurine sodium 10.0
Polyoxyethylene (3) sodium alkyl ether sulfate 20.0
Lauryldimethylaminoacetic acid betaine 10.0
Palm oil fatty acid diethanolamide 4.0
Methylparaben 0.1
Citric acid 0.1
Extract of Production Example 1 2.0
Collagen 5.0
Amamo extract 5.0
Black soybean hydrolyzate 5.0
Hamcho Extract 5.0
Paudalco Bark Extract 5.0
Kakkon Extract 5.0
1,3-butylene glycol 2.0
Amount of purified water totaling 100 parts
処方例17.ヘアシャンプー
処方例16の成分中、製造例1の抽出物に代えて製造例2の抽出物を用いるほかは処方例16と同様にしてヘアシャンプーを得た。
Formulation Example 17. Hair Shampoo A hair shampoo was obtained in the same manner as in Formulation Example 16 except that the extract of Production Example 2 was used instead of the extract of Production Example 1 in the ingredients of Formulation Example 16.
処方例18.ヘアシャンプー
処方例16の成分中、製造例1の抽出物に代えて製造例3の抽出物を用いるほかは処方例16と同様にしてヘアシャンプーを得た。
Formulation Example 18. Hair Shampoo A hair shampoo was obtained in the same manner as in Formulation Example 16 except that the extract of Production Example 3 was used instead of the extract of Production Example 1 in the ingredients of Formulation Example 16.
実施例19.ヘアリンス
[A成分] 部
ポリオキシエチレン(10)硬化ヒマシ油 1.0
塩化ジステアリルジメチルアンモニウム 1.5
塩化ステアリルトリメチルアンモニウム 2.0
2−エチルヘキサン酸グリセリル 1.0
セタノール 3.2
ステアリルアルコール 1.0
メチルパラベン 0.1
製造例1の抽出物 2.0
1,3−ブチレングリコール 5.0
精製水 全量が100部となる量
Example 19. Hair rinse [component A] part polyoxyethylene (10) hydrogenated castor oil 1.0
Distearyldimethylammonium chloride 1.5
Stearyltrimethylammonium chloride 2.0
Glyceryl 2-ethylhexanoate 1.0
Cetanol 3.2
Stearyl alcohol 1.0
Methylparaben 0.1
Extract of Production Example 1 2.0
1,3-butylene glycol 5.0
Amount of purified water totaling 100 parts
Claims (4)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017033749A JP7504415B2 (en) | 2017-02-24 | 2017-02-24 | Hair cosmetics |
JP2024020173A JP2024056871A (en) | 2017-02-24 | 2024-02-14 | Hair cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017033749A JP7504415B2 (en) | 2017-02-24 | 2017-02-24 | Hair cosmetics |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024020173A Division JP2024056871A (en) | 2017-02-24 | 2024-02-14 | Hair cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018138533A true JP2018138533A (en) | 2018-09-06 |
JP7504415B2 JP7504415B2 (en) | 2024-06-24 |
Family
ID=63450912
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017033749A Active JP7504415B2 (en) | 2017-02-24 | 2017-02-24 | Hair cosmetics |
JP2024020173A Pending JP2024056871A (en) | 2017-02-24 | 2024-02-14 | Hair cosmetics |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024020173A Pending JP2024056871A (en) | 2017-02-24 | 2024-02-14 | Hair cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP7504415B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020137707A1 (en) * | 2018-12-28 | 2020-07-02 | 小林製薬株式会社 | Topical composition containing d-chiro-inositol |
CN113384509A (en) * | 2021-06-22 | 2021-09-14 | 科丝美诗(中国)化妆品有限公司 | Composition for preventing hair loss, fixing hair, removing dandruff and controlling oil and application thereof |
CN116392399A (en) * | 2023-03-31 | 2023-07-07 | 太和康美(北京)中医研究院有限公司 | Gli-2 and CYP17A1 two-target-point regulator and application thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0436221A (en) * | 1990-05-29 | 1992-02-06 | Sunstar Inc | Hair tonic |
KR100609210B1 (en) * | 2002-10-05 | 2006-08-02 | 김철정 | Shampoo composition for preventing hair loss |
JP2007246446A (en) * | 2006-03-16 | 2007-09-27 | Sansho Seiyaku Co Ltd | External preparation for skin or hair |
JP2008100943A (en) * | 2006-10-19 | 2008-05-01 | Kenji Okajima | External preparation for skin having action to promote secretion of insulin-like growth factor 1 |
JP2009167121A (en) * | 2008-01-15 | 2009-07-30 | Nihon Kenko Shokuzai Kk | Hair-growing composition |
JP2013040117A (en) * | 2011-08-12 | 2013-02-28 | Shiseido Co Ltd | Collagen production promoter and food composition |
JP2014172849A (en) * | 2013-03-07 | 2014-09-22 | Shiseido Co Ltd | Type i collagen production promoter |
KR20160054087A (en) * | 2014-11-05 | 2016-05-16 | 조길래 | The composition of Caffeoylpentapeptide Cosmetic that has the Constitution of skin Anti-irritant for the Prevention of Hair Loss and the Promotion of Hair Growth |
WO2017019713A1 (en) * | 2015-07-27 | 2017-02-02 | Luiz Francisco Pianowski | Mulateiro-derived compositions and use thereof for preventing hair loss and promoting hair growth |
-
2017
- 2017-02-24 JP JP2017033749A patent/JP7504415B2/en active Active
-
2024
- 2024-02-14 JP JP2024020173A patent/JP2024056871A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0436221A (en) * | 1990-05-29 | 1992-02-06 | Sunstar Inc | Hair tonic |
KR100609210B1 (en) * | 2002-10-05 | 2006-08-02 | 김철정 | Shampoo composition for preventing hair loss |
JP2007246446A (en) * | 2006-03-16 | 2007-09-27 | Sansho Seiyaku Co Ltd | External preparation for skin or hair |
JP2008100943A (en) * | 2006-10-19 | 2008-05-01 | Kenji Okajima | External preparation for skin having action to promote secretion of insulin-like growth factor 1 |
JP2009167121A (en) * | 2008-01-15 | 2009-07-30 | Nihon Kenko Shokuzai Kk | Hair-growing composition |
JP2013040117A (en) * | 2011-08-12 | 2013-02-28 | Shiseido Co Ltd | Collagen production promoter and food composition |
JP2014172849A (en) * | 2013-03-07 | 2014-09-22 | Shiseido Co Ltd | Type i collagen production promoter |
KR20160054087A (en) * | 2014-11-05 | 2016-05-16 | 조길래 | The composition of Caffeoylpentapeptide Cosmetic that has the Constitution of skin Anti-irritant for the Prevention of Hair Loss and the Promotion of Hair Growth |
WO2017019713A1 (en) * | 2015-07-27 | 2017-02-02 | Luiz Francisco Pianowski | Mulateiro-derived compositions and use thereof for preventing hair loss and promoting hair growth |
Non-Patent Citations (4)
Title |
---|
"Ameba人気のブログ", 髪がどんどん生える?!薄毛女の「育毛、目指せ!」挑戦記, JPN6020045351, 30 October 2014 (2014-10-30), ISSN: 0004512439 * |
"抗酸化作用のあるポリフェノールがたっぷり!「ごぼう」で健康生活!,食物繊維に抗酸化作用のポリフェノー", TENKI.JP, JPN6022002004, 18 January 2017 (2017-01-18), ISSN: 0004900094 * |
加藤陽治他: "貯蔵および加熱処理に伴うゴボウのイヌリンの変化", 弘前大学教育学部紀要, vol. 第69号, JPN6022044451, March 1993 (1993-03-01), pages 131 - 135, ISSN: 0004900096 * |
王 蓉他: "ゴボウ中のクロロゲン酸関連成分含量の品種間差異", 日本食品科学工学会誌, vol. 48巻, 11号, JPN6022002005, 2001, pages 857 - 862, ISSN: 0004900095 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020137707A1 (en) * | 2018-12-28 | 2020-07-02 | 小林製薬株式会社 | Topical composition containing d-chiro-inositol |
JP2020109057A (en) * | 2018-12-28 | 2020-07-16 | 小林製薬株式会社 | Composition for external use containing d-chiro-inositol |
JP7425536B2 (en) | 2018-12-28 | 2024-01-31 | 小林製薬株式会社 | External composition containing D-chiro-inositol |
CN113384509A (en) * | 2021-06-22 | 2021-09-14 | 科丝美诗(中国)化妆品有限公司 | Composition for preventing hair loss, fixing hair, removing dandruff and controlling oil and application thereof |
CN116392399A (en) * | 2023-03-31 | 2023-07-07 | 太和康美(北京)中医研究院有限公司 | Gli-2 and CYP17A1 two-target-point regulator and application thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2024056871A (en) | 2024-04-23 |
JP7504415B2 (en) | 2024-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6884608B2 (en) | Compositions and external preparations for skin | |
JP6927660B2 (en) | Topical skin composition and oral composition | |
JP2024056871A (en) | Hair cosmetics | |
JP6246578B2 (en) | Skin cosmetics | |
JP5698586B2 (en) | Cosmetics | |
JP2005022993A (en) | Agent for promoting production of collagen and elastin and ageing-resistant cosmetic containing the same | |
JP5900915B2 (en) | Whitening cosmetics | |
JP6083938B2 (en) | Hair cosmetics | |
JP6910751B2 (en) | Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents | |
JP2016000706A (en) | Cosmetic | |
JP5812562B2 (en) | Cosmetics | |
JP6559948B2 (en) | Skin turnover improver | |
JP7233832B2 (en) | hair cosmetics | |
JP2002128632A (en) | Cosmetic | |
JP7032852B2 (en) | Hair cosmetics | |
JP6375087B2 (en) | Cosmetics | |
JP7257657B2 (en) | antioxidants and cosmetics | |
JP2002284648A (en) | Composition for hair restorer | |
JP2002114629A (en) | Cosmetic | |
JP2020176064A (en) | Composition for hair growth | |
JP6114502B2 (en) | Hair cosmetics | |
JP2019194174A (en) | Skin external preparation | |
JP7265237B2 (en) | Hair composition and external skin composition | |
JP6114488B2 (en) | Fibroblast growth factor production promoter, vascular endothelial growth factor production promoter, and hair cosmetics | |
JP2005154375A (en) | Skin lotion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200221 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201111 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210615 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210816 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220509 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220509 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220519 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220608 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220816 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220907 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20221021 |
|
C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20221114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240605 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7504415 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |